Showing 16,741 - 16,760 results of 27,254 for search '(( 50 ((ns decrease) OR (mean decrease)) ) OR ( 50 ((we decrease) OR (a decrease)) ))', query time: 0.88s Refine Results
  1. 16741

    Insulin Resistance in Relation to Lipids and Inflammation in Type-2 Diabetic Patients and Non-Diabetic People by Ying-Mei Feng (2609680)

    Published 2016
    “…</p><p>Methods</p><p>We studied 798 Chinese patients with type-2 diabetes (53.6% women; mean age, 60.6 years) admitted to a tertiary referral centre and 1060 white Flemish (50.5%; 51.1 years) randomly recruited in Northern Belgium. …”
  2. 16742

    Table1_Retrospective Recall of Psychological Distress Experienced During the First COVID-19 Lockdown in Italy: Results From the ALT RISCOVID-19 Survey.doc by Francesca Bracone (12014342)

    Published 2022
    “…</p><p>Methods: Cross-sectional analysis on 1,880 adults (mean age 48.9 ± 14.5 years) from the web-based ALT RISCOVID-19 survey. …”
  3. 16743

    Maternal β-catenin activity is hyperactivated in <i>nanog</i> mutant. by Mudan He (7017239)

    Published 2020
    “…(H) Relative mRNA level of <i>boz</i> and <i>chd</i> in the embryos of WT, MZ<i>nanog</i>, MZ<i>nanog</i> co-injected with <i>ctnnb1</i> MO (+ <i>β1</i> MO) and MZ<i>nanog</i> co-injected with <i>ctnnb2</i> MO (+ <i>β2</i> MO). Error bars, mean ± SD, **<i>P</i> < 0.01; NS means no significant difference. …”
  4. 16744
  5. 16745

    Results of Multivariate Regression Analyses. by Jeet Gandhi (262339)

    Published 2009
    “…The association coefficient is −0.07, which means after adjusting for <i>EGFR</i> mutation and <i>HER2</i> copy number effects, the IC50 will decrease 0.85 fold when <i>EGFR</i> relative copy number increases 1 unit.…”
  6. 16746

    Influence of point mutations on proton sensitivity. by Katsuya Ohbuchi (559460)

    Published 2016
    “…The F587A, F591A and L670A mutations markedly decreased proton sensitivity. …”
  7. 16747

    Increased Fhl1b activity suppresses specification of pancreatic cells and induces liver. by Jin Xu (31283)

    Published 2016
    “…(H) Quantification of the number (mean±SD) of <i>Tg(ptf1a</i>:GFP<i>)</i><sup><i>jh1</i></sup>-expressing cells in the exocrine pancreas at 50 hpf. …”
  8. 16748

    Ivermectin and albendazole withdrawal period in goat milk by Patrícia Silva Santos (6305066)

    Published 2019
    “…The amount of residues contained in themilk was decreasing in function of time. The mean daily rates of decrease of albendazole residues were 63.34%, 40.18 and 100.0%, from the 2ndto the 4thday, respectively; on the 3rdday after treatment, 50% of the samples showed concentrations ≥ 47.61 μg.mL–1, and on the 4thday, no sample had albendazole residue. …”
  9. 16749
  10. 16750

    Supplemental_Figure_of_Imeglimin_ameliorate_SA-AKI by Hiroyasu Goto (12227927)

    Published 2025
    “…Data are presented as the mean ± SE. Data were analyzed using a two-way analysis of variance (ANOVA) with Šidák’s post-hoc test #p<0.05. …”
  11. 16751

    Effect of environmental factors on the germination of Megathyrsus maximus: an invasive weed in sugarcane in Argentina by Debora C. Cabrera (10460723)

    Published 2021
    “…Both mean germination percentages and CG decreased as osmotic potential became increasingly negative (0 MPa to -0.6 MPa), and as sodium chloride solution concentrations increased (10 to 130 mmol L-1). …”
  12. 16752

    CAR treatment reduced cleaved caspase-3 level after cerebral I/R injury. by Hailong Yu (329340)

    Published 2013
    “…Beta-tubulin was used as a loading control. (B)The quantitative analysis indicated that CAR treatment decreased ratio of cleaved caspase-3 to beta-tubulin. …”
  13. 16753

    LNCaP cell lines expressing Abi1 isoforms exhibit different spreading and morphological phenotypes. by Patrycja M. Dubielecka (249192)

    Published 2010
    “…Iso-2 cell line exhibited a significantly decreased mean cell area as compared to Iso-3 or mock control cell lines. …”
  14. 16754

    Supplementary figure 1 by Cass Dedert (12837572)

    Published 2022
    “…</strong>Primary cortical neurons were incubated in Neurobasal medium containing either 25 mM (control), 50 mM, or 100 mM glucose. After 72 hours of treatment, viability showed a dose-dependent decrease as glucose concentration increased. …”
  15. 16755

    Table_1_Initial experiences using plasma rich in growth factors to treat keratoneuralgia.DOCX by Margaret Wang (13301334)

    Published 2022
    “…The results of this survey and other objective findings were compared before and after PRGF treatment. 16 out of 32 patients (50%) with a mean follow-up period of 33 ± 26 months answered the questionnaire. …”
  16. 16756

    The transient K<sup>+</sup> currents displayed sensitivity towards holding potentials, and the magnitude changes during development. by Snezana Levic (336804)

    Published 2013
    “…(<b>C</b>) Mean difference current density at +0 mV at apical and basal regions of the basilar papilla (pA/pF) at E8, E10, E12, E16, and P2. …”
  17. 16757

    Anchusa italica extract: phytochemical and neuroprotective evaluation on global cerebral ischemia and reperfusion by Akram Torki (5383154)

    Published 2018
    “…Induction of ischemia/reperfusion caused a decrease in the antioxidant capacity of the brain and serum as well as an increase in the malondialdehyde of the brain and serum. …”
  18. 16758
  19. 16759

    DataSheet_1_Identifying hub genes in response to ustekinumab and the impact of ustekinumab treatment on fibrosis in Crohn’s disease.zip by Ying Xu (9172)

    Published 2024
    “…Introduction<p>Crohn’s disease (CD) is a chronic inflammatory disease. Approximately 50% of patients with CD progressed from inflammation to fibrosis. …”
  20. 16760

    Image1_Total flavonoids extracted from Penthorum chinense Pursh mitigates CCl4-induced hepatic fibrosis in rats via inactivation of TLR4-MyD88-mediated NF-κB pathways and regulatio... by Sujuan Wang (1865149)

    Published 2023
    “…Subsequently, rats were randomly assigned to a control group (Control), a carbon tetrachloride (CCl<sub>4</sub>)-induced hepatic fibrosis model group (Model), a positive control group [0.2 mg/(kg∙day)] of Colchicine), and three TFPCP treatment groups [50, 100, and 150 mg/(kg∙day)]. …”